Advances in Systemic Therapy for Ovarian Cancer Over the Past Decade: A Clinical and Molecular Perspective

Monika Abramiuk; Ilona Skrabalak; Malgorzata Satora; Marta Ostrowska-Leśko; Maja Joanna Czech; Julia Majchrzak; Marcin Bobiński

doi:10.12659/MSM.949526

28 August 2025 : Review article

Advances in Systemic Therapy for Ovarian Cancer Over the Past Decade: A Clinical and Molecular Perspective

Monika Abramiuk

^{AEFG 1*}, Ilona Skrabalak

^{EF 2}, Malgorzata Satora

^{AEF 3}, Marta Ostrowska-Leśko

^{AEFG 2}, Maja Joanna Czech^{EF 4}, Julia Majchrzak^{EF 4}, Marcin Bobiński

^{AFG 2}

DOI: 10.12659/MSM.949526

Med Sci Monit 2025; 31:e949526

Authors information Article notes Copyright and License information

Introduction Characteristics of Ovarian Cancer The Idea of Tailored Therapy Mechanisms of Action of Currently Used Agents Clinical Utilization of Targeted Treatments Upcoming Advances Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Platinum resistance definition [29].

Back to the Article

Advances in Systemic Therapy for Ovarian Cancer Over the Past Decade: A Clinical and Molecular Perspective

Your Privacy